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Introduction 
The health of multicellular organism depends not only on the body's ability to produce new 
cells but also on the ability of individual cells to destruct when they become superfluous or 
disordered. Millions of cells are sacrificed every hour. This critical process is essential for the 
development and maintenance of multicellular organism; is termed apoptosis. The 
significance of apoptosis was overlooked for decades. But biologists have recently made 
rapid strides in understanding how cellular suicide is enacted and controlled. It is known 
that aberrant regulation of apoptosis-Ieading to too much or too little apoptosis-probably 
contributes to disorders like cancer, AIDS, Alzheimer's disease and autoimmune diseases 
(rheumatoid arthritis, lupus erythromatosis). 
Death is not bad for the body always. In fact it is necessary for the health and 
well being of multicellular organism. The tadpole deletes its tail during transformation to 
frog; the arthropods delete several appendages/ tissues during metamorphosis; mammals 
erase countless neurons as the nervous system takes shape. Human embryo deletes the 
web between digits during development. The lens of eye, which forms during embryonic 
development, consists of apoptotic cells that have replaced their intemal contents with 
pr~tei n crystalline. Cells composing intestinal villi arise at the base of the villi and over 
several days, travel to the tip. They die there and are sloughed off. Skin cells begin life in 
the deepest layers and then migrate to the surface, undergoing apoptosis along the way. 
The dead cells forms skin's protective layer. The cells lining uterine wall perish by apoptosis 
during menstruation. The cells that become infected by virus or sustain irreparable genetiC 
mutation often kill themselves. T lymphocytes during the developmental stage encountering 
an antigen die by apoptosis. 
h lulh_ 0,. !r, when a cell is 5'_', rely injur( d, by rhysical injury or by 
oxygen/ nutrient deprivation. This death has the following features. The cell and its intemal 
organelles undergo severe swelling/ ballooning due to failure of ion pumps. Another 
hallmark of necrosis is inflammation bringing white blood cells to the site of necrOSis. 
Inflammation also damages the normal tissue in the vicinity. Apoptosis, or programmed cell 
death, is a normal component of the development and health of multicellular organisms. 
Cells die in response to a variety of stimuli and during apoptosis they do so in a controlled, 
regulated fashion. This makes apoptosis dist inct from another form of cell death called 
(yrosis in which uncontrolled cell death leads to lysis of cells, inflammatory responses and 
potentially, to serious heal h problems. Apoptosis, by contrast, is a process in which cell~ 
play an active role in their own death (which is why apoptosis is often referred to as cell 
suicide). Cells that are induced to commit suicide: shrink, have thei r mitochondria break 
down with the release of cytochrome c, develop bubble- like blebs on their surface and have 
the chromatin (DNA and protein) in their nucleus degraded. The chromatin breaks into 
small, membrane-wrapped, fragments. The phospholipid phosphatidylserine, which is 
normally hidden within the plasma membrane, is exposed on the surface. This is bound by 
receptors on phagocytic cells like macrophagesand dedritic cells, which then engulf the ce ll 
fragments. 
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biochemical and morphological changes occur in the cell. A family of proteins known as 
caspases is typically activated in the early stages of apoptosis. These proteins breakdown or 
cleave key cellular substrates that are required for normal cellular function including 
structural proteins in the cytoskeleton and nuclear proteins such as DNA repair enzymes. 
The caspases can also activate other degradative enzymes such as DNases, which begin to 
cleave the DNA in the nucleus. The result of these biochemical changes is appearance of 
morphological changes in the cell. 
Some of these changes are illustrated in Figure 1, which shows time-lapse microscopy 
images of a trophoblast cell undergoing apoptosis. 
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Typically, the cytoplasm begins to shrink following the cleavage of lamins and actin 
filaments (A). Nuclear condensation can also be observed following the breakdown of 
chromatin and nuclear structural proteins, and in many cases the nuclei of apoptotic cells 
take on a "horse-shoe" like appearance (8). Cells continue to shrink (C), packaging 
themselves into a form that allows for easy clearance by macrophages. These phagocytic 
cells are responsible for removing apoptotic cells from tissues in a dean and tidy fashion 
that avoids many of the problems associated with necrotic cell death. In order to promote 
their phagocytosis by macro phages, a"poptotic cells often ungergo plasma membrane 
changes that trigger the macrophage response. One such change is the translocation of 
phosphatidylserine from the inner leaflet of the cell to the outer surface. Membrane changes 
can often be observed morphologically through the appearance of membrane blebs (D) or 
blisters, which often appear towards the end of the apoptotic process. Small vesicles called 
apoptotic bodies are also sometimes observed (D, arrow). In apoptosis cell spends energy, 
as it is an active process initiated by cell's own cleaving enzymes, which are interleukin-l 
converting enzyme like proteases (ICE like proteases). 
The Mechanisms of Apoptosis 
There are three pathways through which apoptosis mechanism is activated. One 
generated by signals arising within the cell. Another briggered by death activators binding 
to receptors at the cell surface. These are TNF-q Lymphotoxin and Fas ligand (FasL). A 
third that may be triggered by dangerous reactive oxygen species 
Apoptosis triggered by internal signals: the intrinsic or mitochondrial pathway 
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In a healthy cell, the outer membranes of its mitochondria express the protein Bd-
2 on their surface. BcI ·2 is bound to a molecule of the protein Apaf-l . Internal damage to 
the cell (e.g., from reactrve oxygen species) causes BcI-2 to release Apaf- l to no longer 
keep cytochrome c from leaking out of the mitochondria. The released cytochrome c and 
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Apaf-l bind to molecules of caspase 9. The resulting complex of cytochrome C, Apaf-l, 
caspase 9 (and ATP) is called the apoptosome. These aggregate in the cytosol. Caspase 
9 is one of a family of over a dozen caspases. They are all proteases. They get their name 
because they cleave proteins - mostly each other - at aspartic acid (Asp) residues). Caspase 
9 cleaves and, in so doing, activates other caspases. The sequential activation of one 
caspase by another creates an expanding cascade of proteolytic activity (rather like that in 
blood clotting and complement activation), which leads to digestion of structural proteins in 
the cytoplasm degradation of chromosomal DNA and phagocytosis of the cell. 
Apoptosis triggered by external signals 
Fig.3 
One method by which cytotoxic T cells 
induce their targets (e.9., vlrus-
infected cells) to commit suicide 
(apoptosis) 
Fas and the TNF receptor are integral membrane proteins with their receptor 
domains exposed at the surface of the cell. Binding of the complementary death activator 
(FasL and TNF respectively) transmits a signal to the cytoplasm that leads to activation of 
caspase 8. Caspase 8 (like caspase 9) initiates a cascade of caspase activation leading to 
Phagocytosis of the cell. When cytotoxiC T cells recognize (bind to) their target, they 
produce more FasL at their surface. This binds with the Fas on the surface of the target 
cell leading to its death by apoptosis. 
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Apoptosis-Inducing Factor CAlF) 
Neurons, and perhaps other cells, have another way to self-destruct that - unlike the 
two paths described above - does not use caspases. Apoptosis-inducing factor (AlF) is a 
protein that is normally located in the inter membrane space of mitochondria. When the cell 
receives a signal telling it that it is time to die, AIF is released from the mitochondria (like 
the release of cytochrome c in the first pathway) migrates into the nucleus and binds to 
DNA, which triggers the destruction of the DNA and cell death. 
There are a number of mechanisms through which apoptosis can be induced in 
cells. The sensitivity of cells to any of these stimuli can vary depending on a number of 
factors such as the expression of pro- and anti-apoptotic proteins (eg. the BcI-2 proteins or 
the Inhibitor of Apoptosis Proteins), the severity of the stimulus and the stage of the cell 
cycle. When cells are subjected to radiation injury or agents that induce mutation, the 
damage spurs the cells to a protein called p53. This protein activates the suicide pathway. 
There are a number of mechanisms through which apoptosis can be induced in 
cells. The sensitivity of cells to any of these stimuli can vary depending on a number of 
factors such as the expression of pro- and anti-apoptotic proteins (eg. the BcI-2 proteins or 
the Inhibitor of Apoptosis Proteins), the severity of the stimulus and the stage of the cell 
cycle. Some of the major stimuli that can induce apoptosis are outlined in the illustration 
below. 
In some cases the apoptotic stimuli comprise extrinsic signals such as the binding 
of-death inducing ligands to cell surface receptors (1) or the induction of apoptosis by 
cytotoxiC T-Iymphocytes by granzyme (4). The latter occurs when T-cells recognise 
damaged or virus infected cells and initiate apoptosis in order to prevent damaged cells 
from becoming neoplastic (cancerous) or virus-infected cells from spreading the infection. 
In other cases apoptosis is initiated following intrinsic signals that are produced 
following cellular stress. Cellulilr stress may occur from exposure to radiation (2) or 
( ":ieals or to V" • ! ; i I' f1llgiJl o:SC be G c- .nsequ : lee of growth factor 
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involvement of the mitochondria (5). The relative ratiOS of the various bcl-2 proteins can 
often determine how much cellular stress is necessary to induce apoptosis. 
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Death receptors are cell surface receptors that transmit apoptosis signals 
initiated by specific ligands. They play an important role in apoptosis and can activate a 
caspase cascade within seconds of ligand binding. Induction of apoptosis via this 
mechanism is therefore very rapid. Death receptors belong to the tumour necrosis factor 
{TN F) gene superfamily and generally can have several functions other than initiating 
apor'r"~ , i s . The besi ( 'laracter. , d of the death receptor< are CD9S (or Fas), TNFR l(TNF 
reCepl( -1) and 1,",,0 ~L:AIL (Tr ' relate·j afloDto~,s indur, . . Iifji1nd) receptors DR4 and ~RS. 
5Igr l<"" oj by tumu ! . -crosis I ' ,r re,· . d ! \ ' l FR1). 
TNF is produced by 1 cells and activated macrophages In response to infection. By 
ligating TNFR1, TNF can have several effects (seeFigure). In some cells it leads to activation 
of NF-kB and AP- l, which leads to the induction of a number of proinflammatory and 
immunomodulatory genes. In some celis, however, TNF can also induce apoptosis, although 
receptor ligation is rarely enough on its own to initiate apoptosis as is the case with C09S 
ligand binding. 
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Viral diseases and cancer 
Two human papilloma viruses (HPV) have been implicated in causing cervical 
cancer. One of them produces a protein (E6) that binds and inactivates the apoptosis 
promoter p53. Epstein-Barr Virus (EBV), the cause of mononucleosis' and a cause of ' 
Burkitt's lymphoma It produces a protein similar to Bel-2 and produces another protein that 
causes the cell to increase its own production of BcI-2. Both these actions make the cell 
more resistant to apoptosis (thus enabling the canc~r cell to continue to proliferate). Even 
cancer cells produced without the partidpation of viruses may have tricks to avoid 
apoptosis. 
Some B-ceilleukemias and lymphomas express high levels of BcI-2, thus blocking 
apoptotic signals they may receive. The high levels result from a translocation of the BCL -2 
gene into an enhancer region for antibody production Melanoma (the most dangerous type 
of skin cancer) cells avoid apoptosis by inhibiting the expression of the gene encoding 
Apaf-l . 
Some cancer cells, especially lung and colon cancer cells, secrete elevated levels of 
a soluble "decoy" molecule that binds to FasL, plugging it up so it cannot bind Fas. Thus, 
cytotoxic T cells (CfL) cannot kill the cancer cells. 
Other cancer cells express high levels of FasL, and can kill any cytotoxic T cells (CfL) that 
try to kill them because CfL also express Fas (but are protected from their own FasL). 
Apoptosis and Organ Transplants 
For many years it has been known that certain parts of the body like, the 
anterior chamber of the eye and the testes are "immunologically privileged sites". Antigens 
witflin these sites fail to elicit an immune response. It turns out that cells in these sites 
differ from the other cells of the body in that they express high levels of FasL at all times. 
Thus antigen-reactive T cells, which express Fas, would be killed when they enter these 
sites. 
This finding ra ises the possibility of a new way of preventing graft rejection. If at 
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immunosuppressive drugs for the rest of the transplant recipient's life would be reduced or 
eliminated. So far, the results in animal experiments have been mixed. Allografts engineered 
to express FasL have shown increased survival for kidneys but not for hearts or islets of 
Langerhans. 
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Binding of TNF alpha to TNFRl results in receptor trimerisation and clustering of 
intracellular death domains. Th is allows binding of an intracellular adapter molecule called 
TRADD (TNFR-associated death domain) via interactions between death domains. TRADD 
has the ability to recruit a number of different proteins to the activated receptor. ' 
Recruitment of TRAF2 (TNF-associated factor 2) leads to activation of NF-1cB and the 
JNK/Ap·l pathway. 
. TRADD can also associate with FADO, which leads to the induction of apoptosis via 
the recruitment and cleavage. of pro-caspase 8. TNFRl is also able to mediate apoptosis 
through the recruitment of an adapter molecule called RAIDD (RIP-associated ICH-l / CEO-
3 homologous protein with a death domain). RAIDO associates with RIP through 
interactions between death domains and can recruit caspase 2 through an interaction with a 
motif, similar to the death effector domain, known as CARD (caspase recruitment domain). 
Recruitment of caspase 2 leads to induction of apoptosis. 
Signaling by COgS I Fas 
There are three main roles of COgS: 
1. CytotoxiC T-cell mediated killing of cells (for example, CTL-mediated killing of 
virus-infected cells) 
2. Deletion of activated T -cells at the end of an immune response 
3. Destruction of inflammatory and immune cells in immune-privileged sites 
,:. The activation of apoptosis through C09S/Fas Signaling is shown in figure. The 
ligand for CD9S (CD9SL or FasL) is a trimer that on association with the receptor promotes 
receptor trimerisation that in turns results in intracellular clustering of parts of the receptor 
called death domains (DD). This allows an adapter protein called FADO (Fas-associated 
death domain) to associate with the receptor through an interaction between homologous 
death domains on the receptor and on FADO. As well as containing a death domain, FADD 
also contains a death effector domain (OED). The death effector domain allows binding of 
pro-caspase 8 to the CD9S·FADD complex Pro·caspase 8 (also known as FUCE) associates 
wi.\:ll ~FADD tho':\,~ Its c·.m- d,,3ji effect; r domc..n, and I,; PC:l' rt cruitment by FADD is 
im.media~ly cleaved to produce ,caspase 8. This tJ:!en triggers <acti~ati9n of execution 
caspases,such as caspase 9. The complex of proteins - CD9S, .FADD and pro-caspase 8 -
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Fig.6 Activation of apoptosis through CD95 I Fas 
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In a number of ways TRAIL (TNF-related apoptosis inducing ligand) is similar in 
action to 0>95. Binding of TRAIL to its receptors DR4 or DR; lJiggers rapid apOptosis in 
n ". II\, cdls, he· J(VC· " " _, r e~, r~<i ,n h . ~." '. I. ", l5.titutive in many 
tissues. The DR4 and DRS receptors contain death domains in their intracellular domain, but 
as yet nO adapter 'molecule (such as FADD 'or TRADD) has been identified' that assooates 
with the receptDtlo nitlate apopto'Sis. Wor{ln'F~ent mice" lias indicated tMt1=ADD 
is not essential for triggering apoptosis via these receptors. 
Since DR4 and DRS mRNA has been shown to be expressed constitutively in several tissues, 
it has been sug ed that there are mechanisms that protect cells from apoptosls. One 
[,1S" I meclt;:;niwi of protc-ction is based on a set of decoy receptors that compete for 
bduj, .1f11,IJI \';i,j I If' D 'i an' : Dr , receptors. The dewy reccptnl:) are called 0cR1 and 
l,1 t f) r' ., . !.I, r>f (P1l'i l wit! . [ 'r<" . DRS receptors for 
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binding to the ligand (TRAIL), however ligation of these receptors does not initiate 
apoptosis since DcRl does not possess a cytoplasmic domain, while DcRl has a truncated 
death domain lacking 4 out of 6 amino acids essential for recruiting adapter proteins. 
BcI-2 proteins 
The bel-2 proteins are a family of proteins involved in the response to apoptosls. 
Some of these proteins (such as bel-2 and bel-XL) are anti-apoptotic, while others (such as 
Bad or Bax) are pro-apoptotic. The sensitivity of cells to apoptotic stimuli can depend on the 
balance of pro- and anti-apoptotic bcl-2 proteins. When there is an excess of pro-apoptotic 
proteins the cells are more sensitive to apoptosis, when there is an excess of anti-apoptotic 
proteins the cells will tend to be less sensitive. 
The pro-apoptotic bel-2 proteins are often found in the cytosol where the act as sensors 
of cellular damage or stress. Following cellular stress they relocate to the surface of the 
mitochondria where the anti-apoptotic proteins are located. This interaction between pro-
and anti-apoptotic proteins disrupts the normal function of the anti-apoptotic bcl-2 proteins 
and can lead to the fo rmation of pores in the mitochondria and the release of cytochrome C 
and other pro-apoptotic molecules from the intermembrane space. This in turn leads to the 
formation of the apoptosome and the activation of the caspase cascade . 
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